ResultsMoneycontrol
Divi's shares jump 4% on 64% profit rise
Positive+44Company event
GreyOak summary
Divi's Laboratories shares rose 4% after reporting a 64% year-on-year increase in September quarter net profit. Revenue and EBITDA grew 35% and 76% respectively, beating estimates. Brokerages like JPMorgan and Goldman Sachs raised targets and maintained positive ratings, citing strong custom synthesis growth. The Nifty Pharma index also gained 1.5%.
What it affects
- Divi's LaboratoriesDIVISLABPositive +44
Shares jumped 4% on strong Q2 results.Rolling sentiment Positive +80
- HealthcarePositive +17
Pharma index rose 1.5% on sector gains.Rolling sentiment Positive +39
Source
Read the original at MoneycontrolMore Divi's Laboratories news
- Buy, Sell Or Hold: Divi's Labs, Tata Power, Kalyan Jewellers, Reliance Industries, L&T And Shriram Finance — Ask ProfitNDTV Profit · Stock view ·
- Scaling up of projects to drive gains for Divi's Labs amid strong Q2 showBusiness Standard · Results ·
- Divi's Market Cap Crosses Rs 3 Lakh CroreNDTV Profit · Company update ·
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·
- Divi's Labs hits 52-week high on record Q2BusinessLine · Results ·